Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)

NCT01109121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Gout
Hyperuricemia

Interventions

DRUG: Combination 400
DRUG: Allopurinol
DRUG: Combination 600

Sponsor

Nuon Therapeutics, Inc.